Kellerhals Carrard advised Ypsomed and Zürcher Kantonalbank as Counsel to the Transaction. The 1’000’000 new registered shares of Ypsomed Holding AG were successfully listed on the...
Ypsomed Group’s CHF 122.5 Million Capital Increase
BKW’s Acquisition of UMB Group
Kellerhals Carrard advised BKW on the deal. BKW acquired the UMB Group, one of the leading independent full-service IT providers in the Swiss market with around 500...
RealUnit Schweiz AG’s Listing of The Bearer Shares on BX Swiss
Kellerhals Carrard advised RealUnit Schweiz AG on the deal. The shares of RealUnit Schweiz AG successfully listed on the BX Swiss on November 29, 2021. With the...
Vifor Pharma’s CHF 20 Million Acquisition of Inositec
Kellerhals Carrard advised Vifor Pharma on the transaction. Vischer advised Inositec on the deal. Vifor Pharma acquired the Swiss firm Inositec AG, a clinical stage biopharmaceutical company...
Netrics’ Acquisition of BlueStone Consulting Group
Kellerhals Carrard advised BlueStone Consulting Group AG on the deal. Bär & Karrer acted as legal advisor to the Netrics group in this transaction. The Netrics...
Kursaal Bern AG’s CHF 15,1 Million Initial Public Offering
Kellerhals Carrard advised The Kursaal Bern AG on the deal. The Kursaal Bern AG, a traditional Swiss company with the three business segments congress center, hotel...
FountainVest Partners-Led Consortium’s Acquisition of Majority Stake in SPT Group
Kellerhals Carrard represented SPT Group on the transaction, while Homburger advised FountainVest Partners. FountainVest Partners, a leading Asian private equity firm, led a consortium of investors...